Exodus Point Capital Management, LP Galectin Therapeutics Inc Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 29,552 shares of GALT stock, worth $78,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,552Holding current value
$78,608% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding GALT
# of Institutions
90Shares Held
9.44MCall Options Held
1.16MPut Options Held
1.98M-
Vanguard Group Inc Valley Forge, PA2.13MShares$5.68 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$4.16 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$3.14 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA863KShares$2.29 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$1.29 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $158M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...